How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Abstract: Decentralized cooperative localization (DCL) is a promising method to determine accurate multirobot poses (i.e., positions and orientations) for robot teams operating in an environment ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Abstract: We propose an image super-resolution method (SR) using a deeply-recursive convolutional network (DRCN). Our network has a very deep recursive layer (up to 16 recursions). Increasing ...
RAPTOR introduces a novel approach to retrieval-augmented language models by constructing a recursive tree structure from documents. This allows for more efficient and context-aware information ...
2024-02-04: Code and pre-trained models are released. 🎊🎊🎊 2023-09-29: This repo is released. Download training and testing datasets and put them into the corresponding folders of datasets/. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results